Aug 21, 2025, 14:59
Primary APS: Warfarin INR 2.5–3.5 Lowers Thrombosis Recurrence, Especially Arterial Events
APS Support UK has shared a post on X:
“Study of 81 pts with primary APS on warfarin found those with INR 2.5–3.5 had reduced rethrombosis risk vs INR <2.5, esp. for arterial events.
Higher anticoagulation intensity = lower recurrence risk.”
Title: Recurrence of thrombosis in patients with primary antiphospholipid syndrome: Emphasis on arterial events
Authors: Antonio R Cabral, Alonso Turrent-Carriles, Irazu Contreras-Yáñez, Ariel Garcia-Torralba, Gabriela Hernandez-Molina
Read the full article here.


Stay updated with Hemostasis Today.
-
Jul 21, 2026, 01:57A New Approach to Understanding Plasmin Generation and Fibrinolysis – RPTH Journal
-
Jul 21, 2026, 01:52Maria Diaz Alonso: Delivering My First International Oral Presentation at ISTH 2026
-
Jul 21, 2026, 01:44Megan Preece: Presenting New Research on Antiphospholipid Syndrome at ISTH 2026
-
Jul 21, 2026, 01:28Dhamirah Nazihah Mohd Nasiruddin: A Milestone in My Haemostasis and Thrombosis Journey at ISTH 2026
-
Jul 21, 2026, 00:55Anita Brikman on PPTA’s First-Half 2026 Achievements
-
Jul 21, 2026, 00:50Caitlin Raymond: Can Therapeutic Plasma Exchange Reduce Microplastics?
-
Jul 21, 2026, 00:46Yohei Hisada: Science, Collaboration, and New Beginnings at ISTH 2026
-
Jul 21, 2026, 00:41Ahmed Koriesh: Inside Our 2026 Stroke Simulation Lab
-
Jul 20, 2026, 21:17Connie Montgomery: Building Community Through the HFA Black Voices Summit